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Recently, in Nature Medicine, Schedin and colleagues define attributes within the involuting postpartum
breastmicroenvironment that promote breast cancermetastasis. Cell invasiveness is controlled by a positive
feedback loop involving COX-2 and fibrillar collagen. NSAIDs suppress tumor progression during postpartum
involution, potentially providing effective agents for intervention in pregnant women.The acquisition of malignant phenotypes
is a long-term, interactive, nonlinear pro-
cess that results in the generation of
a collection of diseases termed cancer.
This multistep, probabilistic process is
not easy to study, and consequently,
much remains to be accomplished in
managing this disease in any of its states.
In select instances, unique physiological
conditions in specific tissues have pro-
vided key insights into isolated steps of
the initiation and progression of malignan-
cies and opportunities to interrupt the pro-
cess. Groundbreaking studies that identi-
fied the human papilloma virus in cervical
cancer, its biological relationship tomalig-
nant transformation, and the development
of a vaccine to control this disease pro-
vide a prime example (zur Hausen, 2009).
The fundamental lessons provided by
these physiologically unique studies ex-
tend far beyond the specific tissue(s)
in which they are conducted. A recently
published study by Dr. Schedin and
colleagues exemplifies this informative
type of approach and provides insights
that will be valuable to a broad audience
of biologists and clinicians (Lyons et al.,
2011). The Schedin group focused on a
physiologically distinct state of breast
tissue that is associated with increased
risk for poor prognosis breast cancer.
This state, called postpartum involution,
coincides with cessation of milk produc-
tion. Soon after birth in the absence of
nursing, or within days of termination of
nursing, the mammary gland initiates a
program that activates epithelial cell death
and stromal remodeling to restore the
breast tissue to a nonsecretory state
typical of nonpregnant tissue.Epidemiological studies of breast can-
cer have taught us that the reproductive
history of an individual woman is of para-
mount importance in determining risk
and outcome. However, deciphering
these influences is often difficult, and the
ensuing linear assumptions can be para-
doxical. For example, while it is appreci-
ated that a full-term pregnancy in young
women is protective against breast can-
cer in the long term, a substantial transient
increase in breast cancer risk has been
observed in the short-term—i.e., after
each pregnancy, in particular in the in-
creasing group of older first-time mothers
(Lyons et al., 2009). In addition to this
higher tumor incidence, women diag-
nosed with breast cancer within five years
of childbirth have a poorer prognosis
and a higher incidence of cancer-related
deaths compared to nulliparous women
or those diagnosed during pregnancy.
This epidemiological study suggests that
events that follow pregnancy, but not
pregnancy itself, are responsible for the
poor prognosis that accompanies post-
partum breast cancer. This information,
coupled with insights from previous
studies (Schedin and Keely, 2011), led
the authors to hypothesize that exposure
to stromal conditions that occur during
postpartum involution promotes several
steps in cancer development.
To test this hypothesis, the authors
utilized state-of-the-art biology and clin-
ical samples to provide insights into the
mechanistic basis of cancer progression
associated with postpartum involution
(Lyons et al., 2011). Three major difficul-
ties in studying the malignant process
include the multistep nature of thisCancer Cell 20, Seprocess, the long latency between initial
events and visible tumor formation, and
the relative infrequency of tumor forma-
tion. Lyons et al. cleverly bypassed these
difficulties by using a premalignant cell
population and choosing a transient time
window during which the incidence of
breast cancer was increased.
In a set of elegantly designed and beau-
tifully executed experiments, the authors
introduced a single bolus of premalignant
human breast cells, MCF10DCIS, into the
mammary glands of murine hosts that
were either nulliparous or experiencing
postpartum involution. Focusing on tumor
progression, the authors measured the
well-established functional endpoints:
proliferation, motility, invasion, and tumor
formation. By three days after the initial
injection, differences in functionally rele-
vant phenotypes were already observed.
While the nulliparous tissue supported
localized growth of MCF10DCIS cells, in
contrast, the postpartum involuting tissue
additionally exhibited small foci of cells
within the mammary gland distal to the
primary site, cells within the mammary
vasculature, and cells within the lung. By
three weeks, the total tumor burden in
involuting tissue was ten-fold that in
nulliparous samples. Tumor cell disper-
sion was independent of tumor size.
A prominent feature of involuting mam-
mary gland tissue is a transient increase
in fibrillar collagen and collagen protein,
whosepresence correlateswith increased
breast cancer risk and tumor cell pro-
liferation, motility, and invasion. Strikingly,
epithelial cells exposed to fibrillar collagen
exhibited an increase in COX-2 enzymatic
activity and subsequent production ofptember 13, 2011 ª2011 Elsevier Inc. 285
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COX-2 is known to promote epithelial
cell proliferation, motility, and invasion, it
suggested itself as an attractive candidate
for controlling the protumorigenic pheno-
types associated with postpartum involu-
tionary tissue. Indeed, consistent with
this hypothesis, exposure to nonsteroid
anti-inflammatory drugs (NSAIDs), a class
of drugs that inhibit COX-2, reversed the
increased tumor cell proliferation, motility,
and invasion.
To determine if the increases in prolifer-
ation, motility, and invasion would be
maintained ex vivo and were dependent
on collagen, tumor cells from the nullipa-
rous or involuting tissue were placed on
matrigel or collagen substrates and ana-
lyzed for relevant phenotypes. Tumor
cells isolated from the involuting tissue
showed an increase in proliferation and
motility compared to cells isolated from
the nulliparous tissue. Increased invasive-
ness was also detected but only in the
presence of collagen. Both cell isolates
were noninvasive when placed in matrigel
without collagen, even when COX-2
activity was upregulated. These data indi-
cate that postpartum involutionary tissue
conditionally promotes malignant pheno-
types in a collagen-dependent manner.
Having determined that COX-2 expres-
sion and collagen deposition collaborate
to generate a conditional positive feed-
back loop that controls tumor cell pheno-286 Cancer Cell 20, September 13, 2011 ª20types, the authors sought relevant evi-
dence in postpartum human breast
cancer. They found that collagen deposi-
tion and orientation in breast tissue of
young nulliparous women differed from
that in postpartum women. Involuting
breast tissue had increased collagen
deposition and more radially aligned
fibers. Importantly, coincident expression
of collagen I and COX-2 proteins identi-
fied a group of women at increased risk
for early relapse of breast cancer and
decreased metastasis-free and overall
survival. Expression of either variable
alone did not correlate with poor prog-
nosis, consistent with the interpretation
that both fibrillar collagen and COX-2 are
required to drive cellular invasion.
Taken together, the data in this report
indicate that premalignant cells, exposed
to increasing amounts of fibrillar collagen,
acquire malignant phenotypes that are
cell autonomous and whose activation
is conditionally dependent on the proper
context, i.e., exposure to fibrillar collagen.
The reversal of these phenotypes upon
exposure of postpartum involutionary
tissue, but not nulliparous tissue, to
COX-2 inhibitors indicates that multiple
inputs into tumor progression are present
but that a substantial fraction of risk can
be modulated by targeted suppression
of COX-2 activity alone. These results
identify windows of opportunity for effec-
tive administration of specific agents,11 Elsevier Inc.such as NSAIDS, in reducing the appear-
ance of breast cancers in postpartum
women.
The significance and implications of
these studies extend beyond the unique
and specific physiological condition that
is observed in postpartum breast tissue.
The stromal characteristics that are so
important in enhancing tumor progression
in this example are also seen in other
instances of tissue states associated
with a high risk for cancer and accompa-
nied by poor prognosis, such as in
wounded or damaged tissues within other
sites of the body and by stromal changes
that are associated with the peritumoral
microenvironment (Tlsty and Coussens,
2006). Future studies need to address
the modulation of these attributes for
clinical purpose.REFERENCES
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